Cardiology

Capabilities

Kensey Nash’s experience with biomaterials and delivery devices began with the invention of the Angio-Seal™ Vascular Closure Device, which pioneered the concept of arterial closure. Kensey Nash continued to establish itself as an innovative leader in cardiovascular technology by developing a platform of endovascular products for treatment of thrombus and chronic total occlusion. Today, we have expanded well beyond our beginnings, leveraging our fundamental biomaterials capabilities to deliver an extensive range of tissue regeneration products for a variety of hard and soft tissue applications.

Products Developed by Kensey Nash

• The Angio-Seal™ Vascular Closure Device
• QuickCat™ Extraction Catheter
• ThromCat™ Mechanical Thrombectomy Catheter System
• Safe-Cross™ Radio Frequency Total Occlusion Crossing System

The Angio-Seal™Vascular Closure Device is exclusively licensed, manufactured, marketed and distributed by St. Jude Medical, Inc. Angio-Seal™ is a trademark of St. Jude Medical Inc.

QuickCat™, ThromCat™ and Safe-Cross™  are trademarks of Spectranetics.

This page is not intended to promote the use of the product in these applications but to suggest the possible clinical applications for which regulatory approvals can be sought.